Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03651869 · ClinicalTrials.gov registry record · Phase 1
Effects of Nicotine in Tobacco Smokers
A Phase 1 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 1
- Development phase
- 221
- Enrollment target
NCT03651869 is a Phase 1 study that has completed, run by University of Southern California. The registered enrollment target is 221 participants.
The verdict
NCT03651869, a Phase 1 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 221 participants
- Enrollment target
Study Summary
This study will examine mechanisms linking Obsessive-Compulsive Disorder symptomatology to tobacco dependence.
Interventions
- DRUG Cigarette 1
- DRUG Cigarette 2
- DRUG Patch 1
- DRUG Patch 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2023-03-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03651869
The ClinicalTrials.gov registry entry for NCT03651869 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cigarette 1 is the first listed.
NCT03651869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03651869 about?
NCT03651869 is a clinical study titled "Effects of Nicotine in Tobacco Smokers". This study will examine mechanisms linking Obsessive-Compulsive Disorder symptomatology to tobacco dependence.
What is the current status of trial NCT03651869?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 221 participants. The study started on 2019-02-04. Estimated completion is 2023-03-23.
What interventions are being tested in trial NCT03651869?
The interventions under investigation include: Cigarette 1 (DRUG), Cigarette 2 (DRUG), Patch 1 (DRUG), Patch 2 (DRUG).
Who is sponsoring clinical trial NCT03651869?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.